CaVenT Study of Additional Catheter-Directed Thrombolysis versus Standard Treatment for Acute Iliofemoral Deep Vein Thrombosis


CaVenT Study of Additional Catheter-Directed Thrombolysis versus Standard Treatment for Acute Iliofemoral Deep Vein Thrombosis
Slides from a presentation at ASH 2011 and transcribed comments from a recent interview with Kenneth A Bauer, MD (1/26/12)

Enden T et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): A randomised controlled trial. Lancet 2012;379(9810):31-8. Abstract

Enden TR et al. Improved functional outcome after additional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: Results of a randomized controlled clinical trial (the CaVenT study). Proc ASH 2011;Abstract LBA-1.

Dr Bauer is Professor of Medicine at Harvard Medical School, Chief of the Hematology Section of the VA Boston Healthcare System and Director of Thrombosis Clinical Research at Beth Israel Deaconess Medical Center in Boston, Massachusetts.